Active Stocks

Wed Apr 02 2025 15:59:29

Indusind Bank share price
702.40 2.88%

Tata Steel share price
154.65 1.01%

Tata Motors share price
671.80 0.06%

Ntpc share price
351.90 -0.07%

Itc share price
408.95 0.57%

Business News > Mint Authors > Jessica Jani

Jessica Jani

Mint Author

ARTICLES BY JESSICA JANI

Wockhardt chairman Habil Khorakiwala.

Wockhardt pins future on novel antibiotics

7 min read . 05:20 AM IST

Manish Gupta, chairman and CEO, Indegene.

Indegene plans to soar in US, expand footprint in Europe

3 min read . 27 Mar 2025

Wipro GE Healthcare announced its plan to invest ₹8,000 crore in India in March 2024.

Wipro GE Healthcare rolls out $1 billion expansion plan

3 min read . 25 Mar 2025

Eli Lilly’s Mounjaro is priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, would cost patients between ₹14,000 to ₹17,500 monthly. (File Photo: Reuters)

Mint Explainer: How big is the weight-loss drug market in India

6 min read . 24 Mar 2025

Eli Lilly launches its blockbuster weight loss drug Mounjaro in India

3 min read . 21 Mar 2025

The joint venture will establish medical and surgical cancer care facilities in Delhi and Mumbai, and plans to expand to 10 cities in the next three years. (iStockphoto)

Narayana Health, VC firm W Health to take cancer care beyond hospitals

3 min read . 20 Mar 2025

While the US is India’s largest importer of chemicals, India also exports to Brazil, the Netherlands, Saudi Arabia, Indonesia, the UAE, Japan, and Germany.

Why Trump’s trade war with China is bad news for Indian chemical exporters

4 min read . 16 Mar 2025

The sales volume of the drug has been growing at a compound annual growth rate of about 1% over the past five year, as per Pharmarack data. (Bloomberg)

Why India’s top generics players are rushing to launch this diabetes drug

4 min read . 13 Mar 2025

Zydus Lifesciences managing director Sharvil Patel.

Zydus eyes global medtech foray with €257 mn acquisition of Amplitude Surgical

3 min read . 11 Mar 2025

Sun Pharmaceuticals, Intas Pharmaceuticals, Torrent Pharmaceuticals, Zydus Lifesciences and Micro Labs reported double-digit growth.

New introductions and price growth driving pharma market growth

2 min read . 10 Mar 2025

Novo Nordisk's chief executive officer Lars Fruergaard Jørgensen.

Ozempic maker Novo Nordisk prepared for generic competition in India

2 min read . 06 Mar 2025

The drugmaker's British-Swedish parent has already received 14 product approvals in the past two years. (REUTERS)

AstraZeneca to bring innovative medicines faster to India, says MD Panchal

3 min read . 06 Mar 2025

Moderator: Jayanth N. Kolla, Founder & Partner, Convergence Catalyst; Dr. Gurukiran Babu Tumma, MD FIDM, VP & Head of Clinical Affairs/Services, Jivi.ai; Dhruv Rastogi, Senior VP & Head of Data Science, Medi Assist; and Abhinav Lal, Co-Founder, Practo Health. (Mint)

AI in healthcare improving patient outcomes - Mint AI Summit 2025

4 min read . 05 Mar 2025

Ameera Shah, promoter and executive chairperson of Metropolis Healthcare.

Metropolis Healthcare amps up North India play with Agra lab chain acquisition

3 min read . 03 Mar 2025

The regulator has earmarked an expenditure of ₹100 crore to develop a digital drug regulatory system.

Central drug regulator creating guidelines for gene therapies, biosimilars: DCGI

2 min read . 27 Feb 2025

Megafine is a Mumbai-based firm manufacturing niche active pharmaceutical ingredients. (Bloomberg)

Motilal Oswal PE arm buys majority stake in bulk drug maker Megafine

2 min read . 25 Feb 2025

Mankind has been driving up chronic portfolio and specialty divisions and is looking at the anti-obesity drug market. (Reuters)

Ozempic play: Mankind Pharma in the fray for weight-loss drugs

5 min read . 24 Feb 2025

The US is India’s largest export market for pharmaceuticals. (Bloomberg)

Bitter pill for Indian pharma as Trump tariffs could hurt exports by $2.25 bn

6 min read . 20 Feb 2025

Indian pharma companies Natco Pharma and Dr. Reddy's Laboratories are shifting their focus to a promising new frontier. (Istockphoto)

Will Natco and Dr. Reddy's bet on weight-loss drug Ozempic's copy pay off?

6 min read . 19 Feb 2025

Maxivision is looking at expanding in states other than those in South India with an immediate focus on Gujarat, Maharashtra and Madhya Pradesh.

Quadria Cap-backed Maxivision plans to expand, eyes IPO by 2027

3 min read . 15 Feb 2025